Afamelanotide in Patients Suffering With Acne Vulgaris
Status:
Completed
Trial end date:
2011-03-08
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the effect of afamelanotide on the facial inflammatory
acne-related lesions in patients with mild to moderate acne vulgaris, including tolerability
of afamelanotide by patients with moderate acne vulgaris and effects of the treatment on
quality of life in eligible patients.